Hyperimmune convalescent plasma

· Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hyperimmune convalescent plasma, covering 2020-09-25 to 2020-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease [Phase 2]